Angus C. Russell's Net Worth
$1.05 Million
Who is Angus C. Russell?
Angus C. Russell has an estimated net worth of $1.05 Million. This is based on reported shares across multiple companies, which include Revance Therapeutics, Inc., Lineage Cell Therapeutics, Inc., Mallinckrodt plc, TherapeuticsMD, Inc., QUESTCOR PHARMACEUTICALS INC, and INTERMUNE INC.
SEC CIK
Angus C. Russell's CIK is 0001534002
Past Insider Trading and Trends
2013 was Angus C. Russell's most active year for acquiring shares with 9 total transactions. Angus C. Russell's most active month to acquire stocks was the month of April. 2014 was Angus C. Russell's most active year for disposing of shares, totalling 11 transactions. Angus C. Russell's most active month to dispose stocks was the month of August. 2015 saw Angus C. Russell paying a total of $487,600.50 for 280,108 shares, this is the most they've acquired in one year. In 2014 Angus C. Russell cashed out on 68,303 shares for a total of $1,269,692.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Revance Therapeutics, Inc. (RVNC) Snapshot price: $5.375
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.09% | 15K |
—
|
—
| 51.51K |
May 1
| |||
Form 4
| +10.72% | 3.53K |
—
|
—
| 36.51K |
May 3
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +22.51% | 6.06K |
—
|
—
| 32.97K |
May 4
| |||
Form 4
| +31.20% | 6.4K |
$15.74 | $100,741.12 | 26.91K |
Dec 13
| |||
Form 4
| +24.32% | 4.01K |
—
|
—
| 20.51K |
May 5
| |||
Form 4
| +57.14% | 6K |
—
|
—
| 16.5K |
May 14
| |||
Form 4
| +75.00% | 4.5K |
—
|
—
| 10.5K |
May 9
| |||
Form 4
| +100.00% | 3K |
—
|
—
| 6K |
May 10
| |||
Form 4
|
∞
| 3K |
—
|
—
| 3K |
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lineage Cell Therapeutics, Inc. (LCTX) Snapshot price: $1.055
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +29.63% | 20K |
$2.59 | $40,365.60 | 87.5K |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +285.71% | 50K |
$3.83 | $191,500.00 | 67.5K |
Nov 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mallinckrodt plc (MNKTQ) Snapshot price: $0.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -51.79K |
$0.13 | -$6,665.24 |
0
|
Nov 12
| |||
Form 4
| -18.87% | -12.04K |
$2.96 | -$35,644.32 | 51.79K |
May 13
| |||
Form 4
| +30.70% | 14.99K |
$15.21 | -$178,930.44 | 63.83K |
May 15
| |||
Form 4
| +115.18% | 26.14K |
—
|
—
| 48.84K |
May 16
| |||
Form 4
| -10.19% | -2.58K |
$15.68 | -$40,391.68 | 22.7K |
Mar 1
| |||
Form 4
| -1.85% | -476.00 |
$37.37 | -$17,788.12 | 25.27K |
Oct 1
| |||
Form 4
| +15.41% | 3.44K |
$51.55 | -$117,843.30 | 25.75K |
Mar 1
| |||
Form 4
| +4.97% | 1.06K |
—
|
—
| 22.31K |
Oct 1
| |||
Form 4
| +5.13% | 1.04K |
—
|
—
| 21.25K |
Jul 21
| |||
Form 4
| +21.54% | 3.58K |
$55.69 | -$25,506.02 | 20.22K |
Mar 16
| |||
Form 4
| +22.02% | 3K |
$131.21 | -$79,513.26 | 16.63K |
Mar 19
| |||
Form 4/A
|
∞
| 13.63K |
—
|
—
| 13.63K |
Aug 14
| |||
Form 4
|
∞
| 21.53K |
—
|
—
| 21.53K |
Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TherapeuticsMD, Inc. (TXMD) Snapshot price: $2.24
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
| +52.10% | 1.98K |
—
|
—
| 5.79K |
Aug 18
| |||
Form 4
| +103.60% | 96.86K |
—
|
—
| 190.36K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +11.98% | 10K |
$2.77 | $27,700.00 | 93.5K |
Aug 23
| |||
Form 4
| +72.16% | 35K |
$2.83 | $98,900.00 | 83.5K |
Aug 14 - Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
| +38.57% | 13.5K |
$5.98 | $80,784.00 | 48.5K |
Aug 25
| |||
Form 4
|
∞
| 35K |
$6.15 | $215,316.50 | 35K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
QUESTCOR PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.36K |
—
|
—
|
0
|
Aug 14
| |||
Form 4/A
|
∞
| 5.11K |
—
|
—
| 5.11K |
Jun 8
| |||
Form 4
| +63.55% | 3.25K |
$46.15 | $149,985.55 | 8.36K |
Jun 14
| |||
Form 4
|
∞
| 5.11K |
—
|
—
| 5.11K |
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||